| UniProt ID | PQBP1_HUMAN | |
|---|---|---|
| UniProt AC | O60828 | |
| Protein Name | Polyglutamine-binding protein 1 {ECO:0000303|PubMed:10332029, ECO:0000303|PubMed:11163963} | |
| Gene Name | PQBP1 {ECO:0000303|PubMed:10332029, ECO:0000303|PubMed:11163963, ECO:0000312|HGNC:HGNC:9330} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 265 | |
| Subcellular Localization | Nucleus . Nucleus speckle . Cytoplasmic granule . Colocalizes with SRSF2 in nuclear speckles (By similarity). Colocalized with POU3F2 (PubMed:10332029). Colocalized with ATXN1 in nuclear inclusion bodies (PubMed:12062018). Localizes to cytoplasmic st | |
| Protein Description | Intrinsically disordered protein that acts as a scaffold, and which is involved in different processes, such as pre-mRNA splicing, transcription regulation, innate immunity and neuron development. [PubMed: 10198427] | |
| Protein Sequence | MPLPVALQTRLAKRGILKHLEPEPEEEIIAEDYDDDPVDYEATRLEGLPPSWYKVFDPSCGLPYYWNADTDLVSWLSPHDPNSVVTKSAKKLRSSNADAEEKLDRSHDKSDRGHDKSDRSHEKLDRGHDKSDRGHDKSDRDRERGYDKVDRERERDRERDRDRGYDKADREEGKERRHHRREELAPYPKSKKAVSRKDEELDPMDPSSYSDAPRGTWSTGLPKRNEAKTGADTTAAGPLFQQRPYPSPGAVLRANAEASRTKQQD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 9 | Phosphorylation | PLPVALQTRLAKRGI CCCHHHHHHHHHCCH | 28.62 | 20068231 | |
| 10 | Methylation | LPVALQTRLAKRGIL CCHHHHHHHHHCCHH | 21.49 | 54558275 | |
| 18 | Acetylation | LAKRGILKHLEPEPE HHHCCHHHHCCCCCH | 44.19 | 26051181 | |
| 18 | Ubiquitination | LAKRGILKHLEPEPE HHHCCHHHHCCCCCH | 44.19 | - | |
| 33 | Phosphorylation | EEIIAEDYDDDPVDY HHCCCCCCCCCCCCH | 16.87 | 28796482 | |
| 40 | Phosphorylation | YDDDPVDYEATRLEG CCCCCCCHHHHCCCC | 14.01 | 28796482 | |
| 43 | Phosphorylation | DPVDYEATRLEGLPP CCCCHHHHCCCCCCC | 24.69 | 28796482 | |
| 51 (in isoform 8) | Phosphorylation | - | 40.89 | 30631047 | |
| 77 | Phosphorylation | TDLVSWLSPHDPNSV CCHHHHCCCCCCCCH | 17.58 | 25159151 | |
| 94 | Phosphorylation | KSAKKLRSSNADAEE HHHHHHHHCCCCHHH | 38.08 | 25159151 | |
| 95 | Phosphorylation | SAKKLRSSNADAEEK HHHHHHHCCCCHHHH | 29.60 | 25159151 | |
| 102 | Acetylation | SNADAEEKLDRSHDK CCCCHHHHHHHHCCC | 47.39 | 26051181 | |
| 106 | Phosphorylation | AEEKLDRSHDKSDRG HHHHHHHHCCCCCCC | 35.39 | 29496963 | |
| 110 | Phosphorylation | LDRSHDKSDRGHDKS HHHHCCCCCCCCCCC | 38.30 | 29496963 | |
| 114 (in isoform 7) | Phosphorylation | - | 39.97 | 20068231 | |
| 116 (in isoform 7) | Phosphorylation | - | 48.89 | 20068231 | |
| 120 (in isoform 7) | Phosphorylation | - | 40.77 | 20068231 | |
| 120 | O-linked_Glycosylation | GHDKSDRSHEKLDRG CCCCCHHHHHHHHCC | 40.77 | 30379171 | |
| 121 (in isoform 7) | Phosphorylation | - | 36.78 | 20068231 | |
| 138 | Phosphorylation | SDRGHDKSDRDRERG CCCCCCCCHHHHHCC | 43.89 | 27134283 | |
| 146 | Phosphorylation | DRDRERGYDKVDRER HHHHHCCHHHHHHHH | 20.86 | 28796482 | |
| 187 | Phosphorylation | RREELAPYPKSKKAV CHHHHCCCCCCHHCC | 20.06 | 21815630 | |
| 191 | Methylation | LAPYPKSKKAVSRKD HCCCCCCHHCCCCCC | 51.37 | 116251901 | |
| 195 | Phosphorylation | PKSKKAVSRKDEELD CCCHHCCCCCCCCCC | 38.17 | 28555341 | |
| 197 | Acetylation | SKKAVSRKDEELDPM CHHCCCCCCCCCCCC | 63.08 | 26051181 | |
| 207 | Phosphorylation | ELDPMDPSSYSDAPR CCCCCCHHHCCCCCC | 37.33 | 28796482 | |
| 208 | Phosphorylation | LDPMDPSSYSDAPRG CCCCCHHHCCCCCCC | 33.76 | 28796482 | |
| 209 | Phosphorylation | DPMDPSSYSDAPRGT CCCCHHHCCCCCCCC | 18.20 | 28796482 | |
| 210 | Phosphorylation | PMDPSSYSDAPRGTW CCCHHHCCCCCCCCC | 29.28 | 28796482 | |
| 214 | Methylation | SSYSDAPRGTWSTGL HHCCCCCCCCCCCCC | 57.82 | 115488641 | |
| 216 | Phosphorylation | YSDAPRGTWSTGLPK CCCCCCCCCCCCCCC | 19.95 | 27251275 | |
| 218 | Phosphorylation | DAPRGTWSTGLPKRN CCCCCCCCCCCCCCC | 16.66 | 25159151 | |
| 219 | Phosphorylation | APRGTWSTGLPKRNE CCCCCCCCCCCCCCC | 34.01 | 29396449 | |
| 229 | Phosphorylation | PKRNEAKTGADTTAA CCCCCCCCCCCCCCC | 44.65 | 29396449 | |
| 233 | Phosphorylation | EAKTGADTTAAGPLF CCCCCCCCCCCCHHH | 20.14 | 29396449 | |
| 234 | Phosphorylation | AKTGADTTAAGPLFQ CCCCCCCCCCCHHHH | 18.30 | 20068231 | |
| 245 | Phosphorylation | PLFQQRPYPSPGAVL HHHHCCCCCCCCHHH | 20.66 | 22617229 | |
| 247 | Phosphorylation | FQQRPYPSPGAVLRA HHCCCCCCCCHHHHH | 30.07 | 25159151 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PQBP1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PQBP1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 309500 | Renpenning syndrome 1 (RENS1) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247, AND MASSSPECTROMETRY. | |